Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded
- Contract number
- SPE2DB25FQ0L3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,323
Award facts
- Contract value 100% obligated
- $28,323.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,323.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Gamunex-C (immune globulin intravenous [human], 20 g/200 mL vial). The contract, which is not set-aside and competitively awarded, requires performance completion by September 18, 2025, with fulfillment at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vehicle that extends through December 2026 and authorizes the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant position within the federal medical supply chain, particularly serving the Defense Logistics Agency's medical procurement needs. The Gamunex-C delivery represents one of many pharmaceutical products the contractor supplies through its DLA Troop Support contract, which encompasses specialty medications, vaccines, generic and brand-name drugs, and medical supplies across multiple therapeutic domains. The company's contract portfolio demonstrates consistent capability to meet federal procurement requirements through open competition across a wide spectrum of medical product categories supporting Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ0L3?
SPE2DB25FQ0L3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FQ0L3 worth?
The government has obligated $28,323 on SPE2DB25FQ0L3.
Is contract SPE2DB25FQ0L3 an order under another contract?
Yes. SPE2DB25FQ0L3 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0L3 competed?
The extent of competition for SPE2DB25FQ0L3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award